Patent · US Active

Anti-PD-1 antibodies and methods of treatment

US11518808B2 · kind B2 · utility

3Cited by

58References

21Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Khaled M. K. Z. Ali · Thousand Oaks, US
Neeraj Jagdish Agrawal · Thousand Oaks, US
Gunasekaran Kannan · Daly City, US
Ian Foltz · Burnaby, CA
Zhulun Wang · Palo Alto, US
Daren Bates · Thousand Oaks, US
Marissa MOCK · Newbury Park, US
Shunsuke Takenaka · Thousand Oaks, US

Key dates

Filing date	Jan 11, 2019
Grant date	Dec 6, 2022
Priority date	—
Expiry date	Mar 11, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are PD-1 antigen-binding proteins and related nucleic acids, vectors, host cells, kits and pharmaceutical compositions. Methods of making PD-1 antigen-binding proteins and methods of treating a subject are further provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.